ZNF322 (zinc finger protein 322) is a transcriptional activator containing nine tandem C2H2-type zinc finger motifs that regulates gene expression through multiple signaling pathways 1. The protein localizes to both nucleus and cytoplasm and functions as a positive regulator of transcription, particularly activating SRE and AP-1 elements in MAPK signaling pathways 1. ZNF322 promotes cancer progression through several mechanisms: it upregulates sonic hedgehog (Shh) expression to enhance neo-angiogenesis in lung cancer as part of a Kras/YY1/ZNF322A/Shh transcriptional axis 2, and directly regulates ADD1 and CCND1 promoters to promote cell proliferation and metastasis 3. AKT-mediated phosphorylation at multiple sites (Thr-150, Ser-224, Thr-234, Thr-262) enhances ZNF322A protein stability and transcriptional activity by improving DNA binding affinity and chr6 association 3. Clinically, ZNF322 expression correlates with poor prognosis in multiple cancer types including lung, gastric, prostate, and soft tissue sarcomas 2456. The protein is targeted by miR-4317, which suppresses gastric cancer cell proliferation by reducing ZNF322 levels 4, highlighting its potential as a therapeutic target.